Welcome to Horizon, DLA Piper’s monthly bulletin reporting on late-breaking legislative and policy developments in ESG. Our aim is to scan ...

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.

The U.S. Supreme Court’s 2025 term delivered two decisions reshaping environmental and administrative law. In City and County ...

On 17 June 2025, the European Commission (the "Commission") published its proposed measures to revive the securitisation framework in the ...

America’s AI Action Plan and the Trump administration's related Executive Order signify a radical shift in U.S. data center ...

How positive you feel depends on your perspective (doi:10.1136/bmj-2025-084613).3 The rapid introduction of physician associates and anaesthesia associates was, in an era of self-inflicted damage, ...

The moves come after the S&P 500 and the Nasdaq Composite hit new all-time and closing highs during Monday’s trading session.

Rather than chase enterprise contracts with large hospital systems, Freed has focused on small clinics and solo practitioners.

While artificial intelligence (AI) investments offer significant growth and profitability potential for insurance companies, they also bring new risks ...

As early as 2005, Gritz and colleagues drew attention to clinical trialists missing the potential impact of tobacco use on cancer treatment outcomes, as smoking status was rarely recorded in cancer ...

Who is leading the artificial intelligence (AI) “arms race” — the US or China? To judge by the past decade, the answer might ...

The current intersection of judicial practice and emerging legal technologies presents a moment that calls for both openness ...